Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
about
MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancersMicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentMethylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBMInterplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approachesSerum miRNA signature in Moyamoya disease.Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.Glucose Metabolism Reprogrammed by Overexpression of IKKε Promotes Pancreatic Tumor Growth.Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistanceUpregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma.Peri-foci adipose-derived stem cells promote chemoresistance in breast cancerMicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.MicroRNA-129-5p Regulates Glycolysis and Cell Proliferation by Targeting the Glucose Transporter SLC2A3 in Gastric Cancer Cells.
P2860
Q26745980-F04CA924-51C7-43B8-8E1D-F67A1CBF10B3Q26747273-6E63B23C-FE3C-4AD8-8A22-9CE913329B9DQ26778918-22CF01B7-B546-43D4-8460-02D27C60DDFFQ33648797-19DB9337-06B6-488F-824F-69C87532147BQ33835913-0FFD9B10-9DA2-442D-943D-19A125EE6953Q34004659-FAFE7948-0628-412E-A455-F2E4ED5AAFF0Q34311253-F2EE38CF-EAEF-4D74-929E-AF698C43B973Q34409620-26A1EB22-B44E-451C-878F-A80EEFA0E174Q35741033-310CFBDD-2525-49DA-B15C-56D86A39A239Q35943345-097D1A3B-EF82-4FDD-8E2E-F02C061F6FEAQ37098282-7F96498B-D120-4C50-908E-88DF851A07B4Q38189850-084D1A31-779F-4FA8-A254-86CED1BAE1D2Q38683271-DCA16C2F-FD2B-40CC-9D93-B5E2BA3C8A31Q38727377-B6E50D27-E1FA-48AE-A53A-A9019818ABEAQ38797514-6AE2A40A-E3EF-4282-8C62-69E3D72BFEBDQ38928373-CD8CF868-D320-4A3D-A706-6D423DEA0364Q41163628-4CECD318-7734-4E61-A089-569B8CCBE985Q41208796-096D45F5-B9CF-471A-8A9C-0F021B94DBF5Q55258939-44D033F2-D24C-4792-BDF6-9168A1D9AEB6
P2860
Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@ast
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@en
type
label
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@ast
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@en
prefLabel
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@ast
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@en
P2093
P2860
P356
P1433
P1476
Decreased miR-106a inhibits gl ...... on by targeting SLC2A3 in GBM.
@en
P2093
Dong-Wei Dai
Guo-Sheng Han
Jian-Min Liu
Lai-Xing Wang
Wen-Yuan Zhao
Yi-Qun Cao
Zhi-Jian Yue
P2860
P2888
P356
10.1186/1471-2407-13-478
P407
P577
2013-10-14T00:00:00Z
P5875
P6179
1001864881